| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |